Concomitant JAK2 V617F-positive polycythemia vera and B-cell chronic lymphocytic leukemia in three patients originating from two separate hematopoietic stem cells

American Journal of Hematology

Volumn 88, Issue 2, 2013, Pages 157-158

  Swierczek, Sabina ^a   Nausova, Jitka ^b   Jelinek, Jaroslav ^c   Liu, Enli ^d   Roda, Paul ^e   Kucerova, Jana ^b   Jarosova, Marie ^b   Urbankova, Helena ^b   Indrak, Karel ^b   Prchal, Josef T ^a   Divoky, Vladimir ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR CELL AND GENE THERAPY   (United States)

^e Geisinger/Hazleton Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2;

AGED; ALLELE; B CELL LEUKEMIA; B LYMPHOCYTE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; GENE MUTATION; GENOTYPE; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LETTER; MONOCYTE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; T LYMPHOCYTE; X CHROMOSOME;

AGED; ALLELES; AMINO ACID SUBSTITUTION; B-LYMPHOCYTES; BLOOD PLATELETS; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; FEMALE; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; JANUS KINASE 2; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTATION; POLYCYTHEMIA VERA; T-LYMPHOCYTES; X CHROMOSOME INACTIVATION;

EID: 84872950600     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23362     Document Type: Letter

References (14)

1. Adamson JW, Fialkow PJ, Murphy S, et al. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Eng J Med 1976;295:913-916.
2. Delhommeau F, Dupont S, Tonetti C, et al. Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis. Blood 2007;109:71-77.
3. Wang X, Prakash S, Lu M, et al. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest, in press.
4. Kikushige Y, Ishikawa F, Miyamoto T, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 2011;20:246-259.
5. Weigert O, Weinstock DM. The evolving contribution of hematopoietic progenitor cells to lymphomagenesis. Blood 2012;120:2553-2561.
6. Henry L, Carillo S, Jourdan E, et al. Association of essential thrombocythemia and chronic lymphocytic leukemia: Absence of the V617F JAK2 mutation in the lymphoid compartment. Am J Hematol 2007;82:500-501.
7. Hussein K, Brakensiek K, Ballmaier M, et al. Bock O, Kreipe H. B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 2006;77:539-541.
8. Stijnis C, Kroes WG, Balkassmi S, et al. No evidence for JAK2 mutation in monoclonal B cells in 2 patients with polycythaemia vera and concurrent monoclonal B cell disorder. Acta Haematol 2012;128:183-186.
9. Kralovics R, Teo SS, Li S, et al. Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders. Blood 2006;108:1377-1380.
10. Nussenzveig RH, Swierczek SI, Jelinek J, et al. Polycythemia vera is not initiated by JAK2V617F mutation. Exp Hematol 2007;35:32-38.
11. Pardanani A, Lasho TL, Finke C, et al. Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes. Stem Cells 2007;25:2358-2362.
12. Skoda R, Prchal JT. Lessons from familial myeloproliferative disorders. Semin Hematol 2005;42:266-273.
13. Rumi E, Passamonti F, Elena C, et al. Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: A study of 1, 915 patients. Haematologica 2011;96:454-458.
14. Vannucchi AM, Masala G, Antonioli E, et al. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Cancer Epidemiol Biomarkers Prev 2009;18:2068-2073.